0000950170-23-069051.txt : 20231208 0000950170-23-069051.hdr.sgml : 20231208 20231208161508 ACCESSION NUMBER: 0000950170-23-069051 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20231204 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20231208 DATE AS OF CHANGE: 20231208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 231475559 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 8-K 1 agen-20231204.htm 8-K 8-K
false000109897200010989722023-12-042023-12-04

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 04, 2023

 

 

AGENUS INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

000-29089

06-1562417

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

3 Forbes Road

 

Lexington, Massachusetts

 

02421

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 781 674-4400

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.01 par value per share

 

AGEN

 

The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On December 4, 2023, Agenus Inc. (the “Company") was notified by the Nasdaq Stock Market's Listing Qualifications Department that the Company’s common stock's closing bid price had not met the $1.00 minimum bid price requirement for 31 consecutive business days, as required by Nasdaq Listing Rule 5550(a)(2). This situation, however, will not impact the listing of the Company's common stock on the Nasdaq Capital Market for a minimum of 180 days with the possibility of an extension of another 180 days.

The Company has been granted an initial automatic 180-day period, ending on June 3, 2024, to rectify this situation and achieve compliance with the minimum bid price requirement. During this period, the Company's common stock needs to maintain a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days for the Company to regain compliance.

In the event that compliance is not achieved by June 3, 2024, the Company could be eligible for an additional 180-day period to meet the requirement. Eligibility for this extension includes meeting the continued listing requirement of market value and all other initial listing standards for the Nasdaq Capital Market, except for the minimum bid price. The Company would also need to indicate its commitment to resolving this deficiency.

Should the Company not meet the minimum bid price requirement within the given periods and any granted extensions, Nasdaq will issue a delisting notice. However, the Company retains the right to request a review of this decision by a Nasdaq hearing panel and can further appeal any panel decision to the Nasdaq Listing and Hearing Review Council. There can be no assurance that, if the Company decides to appeal the delisting determination, such appeal would be successful.

In addressing the current noncompliance with the Nasdaq minimum bid price requirement, the Company remains confident in its ability to resolve this issue. This confidence is grounded in ongoing developments and initiatives that are aligned with the Company’s strategic goals and that the Company expects to enhance the Company's value and contribute to an appreciation of its stock price, thereby achieving compliance with the Nasdaq requirement. While a reverse stock split remains a consideration, it is not the primary focus at this stage. The Company cannot guarantee that it will be able to meet the Nasdaq listing requirements, but is dedicated to leveraging its business strengths and market opportunities to organically drive stock price growth and sustain its compliance with Nasdaq's listing standards.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

Date:

December 8, 2023

By:

/s/ Garo H. Armen

 

 

 

Garo H. Armen, Chairman and CEO

 

 EX-101.SCH 2 agen-20231204.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 agen-20231204_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications EX-101.PRE 4 agen-20231204_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Document And Entity Information
Dec. 04, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 04, 2023
Entity Registrant Name AGENUS INC.
Entity Central Index Key 0001098972
Entity Emerging Growth Company false
Entity File Number 000-29089
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 06-1562417
Entity Address, Address Line One 3 Forbes Road
Entity Address, City or Town Lexington
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02421
City Area Code 781
Local Phone Number 674-4400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.01 par value per share
Trading Symbol AGEN
Security Exchange Name NASDAQ
XML 6 agen-20231204_htm.xml IDEA: XBRL DOCUMENT 0001098972 2023-12-04 2023-12-04 false 0001098972 8-K 2023-12-04 AGENUS INC. DE 000-29089 06-1562417 3 Forbes Road Lexington MA 02421 781 674-4400 false false false false Common Stock, $0.01 par value per share AGEN NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports agen-20231204.htm agen-20231204.xsd agen-20231204_lab.xml agen-20231204_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "agen-20231204.htm": { "nsprefix": "agen", "nsuri": "http://www.agenusbio.com/20231204", "dts": { "inline": { "local": [ "agen-20231204.htm" ] }, "schema": { "local": [ "agen-20231204.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "agen-20231204_lab.xml" ] }, "presentationLink": { "local": [ "agen-20231204_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_c55b6d41-2319-4829-98be-418bbfb4451f", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "agen-20231204.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_c55b6d41-2319-4829-98be-418bbfb4451f", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "agen-20231204.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.agenusbio.com/20231204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 13 0000950170-23-069051-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-23-069051-xbrl.zip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end